Home/Filings/4/0001227025-21-000248
4//SEC Filing

SOPHIE MICHAEL J 4

Accession 0001227025-21-000248

CIK 0001227025other

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 6:30 PM ET

Size

9.5 KB

Accession

0001227025-21-000248

Insider Transaction Report

Form 4
Period: 2021-11-04
Transactions
  • Exercise/Conversion

    Common Stock

    2021-11-04$8.56/sh+5,228$44,75229,050 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2021-11-04$15.04/sh5,228$78,6293,732 total
    Exercise: $8.56Exp: 2030-06-01Common Stock (5,228 underlying)
  • Sale

    Common Stock

    2021-11-04$15.04/sh5,228$78,62923,822 total
  • Sale

    Common Stock

    2021-11-04$15.04/sh12,160$182,88611,662 total
Footnotes (2)
  • [F1]Sale pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • [F2]This option shall vest ratably at a rate of 1/12th of the total number of shares granted on each monthly anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company.

Issuer

NEOPHOTONICS CORP

CIK 0001227025

Entity typeother

Related Parties

1
  • filerCIK 0001209534

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 6:30 PM ET
Size
9.5 KB